Activity in vitro of new beta-lactam beta-lactamase inhibitor combinations against Burkholderiacepacia Complex (Bcc) and Burkholderia gladioli (Bgl) isolated from patients with cystic fibrosis Navegación de entradas EMERGENCE OF HYPER-EPIDEMIC CLONES OF ENTEROBACTERALES CLINICAL ISOLATES CO-PRODUCING KPC AND METALLO-BETA-LACTAMASES DURING THE COVID-19 PANDEMIC Activity of cefiderocol against carbapenemase-producing Enterobacterales (CPE) in the postCOVID-19 era: results of a prospective, multicenter study in Argentina